 |
Bathroom DiariesAuthor: Sofia Din, MD
Please navigate the complexities of aging with Dr. Sofia Din, the Medical Director of an anti-aging clinic in New York! Dr. Din is a board-certified Family Medicine MD who specializes in lifting your body out of its naturally programmed pauses and failures throughout your lifespan. Even though the core of her work deals with "menopause and andropause," she is best known for her work in the magical wonderlands of beauty, cosmetics, skin, and haircare. Learn about the best-kept secrets of the rich and famous as you explore the rapidly evolving wellness market and its numerous FDA-cleared lotions, potions, and energy devices in the United States. In these sessions, Dr. Din will also dive into the nature of perceptions of self that emerge as your consciousness grows deeper into time. Language: en Genres: Alternative Health, Health & Fitness Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
E.204 PEPTIDE PLAYBOOK – PART 4 Somatopause in the GLP-1 Era: A Metabolic-Hormonal Shift We Are Only Beginning to Understand
Episode 204
Wednesday, 1 April, 2026
In this episode of Bathroom Diaries, I sit down again with Dr. Rob Frankel to talk about something most people have never heard of — somatopause. We talk a lot about menopause and andropause. But there is another hormonal shift that affects both men and women starting as early as their 30s: the gradual decline in growth hormone. This conversation is Part 4 of my Peptide Playbook series, where we explore how growth hormone signaling changes over time, why IGF-1 testing matters, and how peptides like tesamorelin, CJC-ipamorelin, and sermorelin may support the body's own natural growth hormone production. In this episode, we discuss: ✨ What somatopause actually is ✨ Why IGF-1 is the most useful marker to evaluate growth hormone decline ✨ How muscle loss, fat gain, fatigue, poor sleep, and brain fog may be connected ✨ The role of growth hormone analog peptides ✨ Why sleep quality and sugar intake affect nighttime hormone release ✨ How GLP-1 therapies support metabolic health and hormone balance ✨ The connection between fatty liver, insulin resistance, and longevity ✨ Who is (and is not) a candidate for peptide-based support ✨ The real clinical studies behind these therapies My goal with this series is simple: to demystify longevity medicine and bring medically responsible conversations about peptides into the open — so patients can make informed decisions with qualified physicians. Somatopause is rarely discussed, but understanding it can change how we think about aging, metabolism, cognition, and strength across the lifespan. If you're interested in hormone optimization, peptide therapy, or proactive aging strategies, this episode is for you. 00:00 Introduction – What is Somatopause? 02:05 Why Growth Hormone Declines After Age 30 04:10 IGF-1 Explained: The Best Marker for Growth Hormone 07:05 Symptoms of Somatopause (Muscle Loss, Fat Gain, Memory Changes) 10:20 Why Doctors Rarely Test Growth Hormone 13:05 Growth Hormone vs Growth Hormone Analogs 16:10 Tesamorelin, CJC-Ipamorelin & Sermorelin Explained 19:15 Are Growth Hormone Peptides Safe? 22:10 Growth Hormone Use in Athletes – What's Appropriate? 25:00 Why Peptides Are Cycled (Receptor Sensitivity Explained) 28:05 Sleep, Sugar & Somatostatin: Hidden Hormone Blockers 31:10 How Sugar Reduces Growth Hormone Production 33:20 GLP-1 Medications & Their Role in Hormone Optimization 36:15 Fatty Liver, Insulin Resistance & Longevity Risk 39:20 Tesamorelin Study: Reducing Visceral Fat by 40% 42:05 Traumatic Brain Injury Study & Growth Hormone Deficiency 45:00 Memory, Cognition & Executive Function Improvements 47:15 Who Should NOT Take Growth Hormone Peptides 49:05 Cost of Growth Hormone Analog Therapy 51:10 Best Blood Tests to Evaluate Somatopause (IGF-1 & Fasting Insulin) 53:00 Final Thoughts: Why Somatopause Matters for Longevity
